Cargando…
Improving the Utility of Polygenic Risk Scores as a Biomarker for Alzheimer’s Disease
The treatment of complex and multifactorial diseases constitutes a big challenge in day-to-day clinical practice. As many parameters influence clinical phenotypes, accurate diagnosis and prompt therapeutic management is often difficult. Significant research and investment focuses on state-of-the-art...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305482/ https://www.ncbi.nlm.nih.gov/pubmed/34209762 http://dx.doi.org/10.3390/cells10071627 |